n-acetylneuraminoyllactose has been researched along with Disease Models, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, C; Choi, EJ; Choi, S; Eyun, SI; Han, SJ; Jeon, J; Jung, H; Kang, LJ; Kim, HY; Kim, J; Kwon, H; Lee, CG; Lee, H; Nam, J; Oh, E; Park, EJ; Song, CU; Yang, S | 1 |
| Cho, C; Jeon, J; Kang, LJ; Kim, W; Lee, KM; Park, TJ; Song, EK; Yang, S | 1 |
| Chen, X; Comstock, SS; Donovan, SM; Hester, SN; Kuhlenschmidt, MS; Kuhlenschmidt, TB; Li, M; Monaco, MH | 1 |
| Carcenac, C; Cottet, C; Fort, S; Pignot-Paintrand, I; Savasta, M; Woerly, S | 1 |
| Bering, SB; Brunse, A; Eskildsen, SF; Heckmann, AB; Obelitz-Ryom, K; Olesen, JL; Overgaard, SH; Pankratova, S; Ringgaard, S; Rydal, MP; Sangild, PT; Skovgaard, K; Thymann, T; Wang, B | 1 |
| Malicdan, MC; Nishino, I; Noguchi, S | 1 |
| Dubois, A; Heman-Ackah, LM; Mysore, JV; Simon, PM; Wigginton, T; Zopf, D | 1 |
| Banfield, E; Buck, RH; Fulton, WB; Goehring, KC; Hackam, DJ; Jia, H; Kovler, M; Ladd, MR; Lu, P; Niño, DF; Prindle, T; Sodhi, CP; Wang, S; Werts, AD; Wipf, P; Yamaguchi, Y; Zhou, Q | 1 |
| Cho, A; Hayashi, YK; Malicdan, MC; Mine, T; Nishino, I; Noguchi, S; Nonaka, I; Yamamoto, T; Yonekawa, T | 1 |
1 review(s) available for n-acetylneuraminoyllactose and Disease Models, Animal
| Article | Year |
|---|---|
[Animal model of distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy and preclinical trial with sugar compounds].
Topics: Administration, Oral; Animals; Disease Models, Animal; Distal Myopathies; Drug Evaluation, Preclinical; Hexosamines; Humans; Inclusion Bodies; Lactose; Mice; Mice, Transgenic; N-Acetylneuraminic Acid; Sialic Acids; Vacuoles | 2010 |
8 other study(ies) available for n-acetylneuraminoyllactose and Disease Models, Animal
| Article | Year |
|---|---|
3'-Sialyllactose prebiotics prevents skin inflammation via regulatory T cell differentiation in atopic dermatitis mouse models.
Topics: Animals; Cytokines; Dermatitis, Atopic; Disease Models, Animal; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Oligosaccharides; Prebiotics; Skin; T-Lymphocytes, Regulatory | 2020 |
3'-Sialyllactose protects against osteoarthritic development by facilitating cartilage homeostasis.
Topics: Administration, Oral; Animals; Cartilage, Articular; Chondrocytes; Collagen Type II; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Homeostasis; Inflammation Mediators; Interleukin-1beta; MAP Kinase Signaling System; Matrix Metalloproteinase 13; Matrix Metalloproteinase 3; Menisci, Tibial; Mice; NF-kappa B; Oligosaccharides; Osteoarthritis; Proteoglycans; SOX9 Transcription Factor; Sulfates | 2018 |
Human milk oligosaccharides inhibit rotavirus infectivity in vitro and in acutely infected piglets.
Topics: Acute Disease; Animals; Diet; Dietary Carbohydrates; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Lactose; Milk, Human; N-Acetylneuraminic Acid; Oligosaccharides; RNA, Messenger; Rotavirus; Rotavirus Infections; Species Specificity; Swine; Viral Nonstructural Proteins; Virus Attachment; Virus Replication | 2013 |
Development of a sialic acid-containing hydrogel of poly[N-(2-hydroxypropyl) methacrylamide]: characterization and implantation study.
Topics: Animals; Antibodies, Monoclonal; Axons; Biocompatible Materials; Corpus Striatum; Disease Models, Animal; Dopamine; Fluorescence; G(M3) Ganglioside; Hydrogels; Immunohistochemistry; Implants, Experimental; Materials Testing; Microscopy, Confocal; Microscopy, Electron, Scanning; Oligosaccharides; Oxidopamine; Particle Size; Plant Lectins; Polymethacrylic Acids; Rats; Surface Properties; Temperature; Time Factors; Wheat Germ Agglutinins | 2008 |
Bovine Milk Oligosaccharides with Sialyllactose Improves Cognition in Preterm Pigs.
Topics: Animals; Brain; Cattle; Cognition; Disease Models, Animal; Female; Lactose; Magnetic Resonance Imaging; Male; Maze Learning; Milk; Pregnancy; Premature Birth; Sialic Acids; Swine | 2019 |
Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound.
Topics: Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Disease Models, Animal; Drug Therapy, Combination; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lactose; Liver Function Tests; Macaca mulatta; Organometallic Compounds; Proton Pump Inhibitors; Salicylates; Sialic Acids | 1999 |
The human milk oligosaccharides 2'-fucosyllactose and 6'-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling.
Topics: Animals; Animals, Newborn; Apoptosis; Cell Line; Disease Models, Animal; Enterocolitis, Necrotizing; Humans; Ileum; Inflammation Mediators; Intestinal Mucosa; Lactose; Mice; Milk, Human; Molecular Docking Simulation; Signal Transduction; Sus scrofa; Toll-Like Receptor 4; Trisaccharides; Weight Loss | 2021 |
Sialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice.
Topics: Aging; Amyloid beta-Peptides; Animals; Body Weight; Cells, Cultured; Creatine Kinase; Disease Models, Animal; Distal Myopathies; Enzyme-Linked Immunosorbent Assay; Hexosamines; Lactose; Mice; Muscle Contraction; Muscle, Skeletal; Mutation; Myoblasts; N-Acetylneuraminic Acid; Peptide Fragments; Phenotype | 2014 |